Focus: Steel Therapeutics is a biotechnology company based in Iowa City with a diversified pipeline spanning metabolic diseases, oncology, nephrology, and cardiovascular indications. The company operates with minimal publicly disclosed scale and focuses on medicated wipe technology.
Profile data last refreshed 1h ago · AI intelligence enriched 1w ago
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
Steel Therapeutics presents a high-risk, high-learning opportunity suitable only for early-career scientists seeking startup exposure and willing to tolerate financial and operational uncertainty.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Steel Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Steel Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles